These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1740413)

  • 1. Role of thrombin exosites in inhibition by heparin cofactor II.
    Rogers SJ; Pratt CW; Whinna HC; Church FC
    J Biol Chem; 1992 Feb; 267(6):3613-7. PubMed ID: 1740413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dysthrombins Quick I and II by heparin cofactor II and antithrombin.
    Phillips JE; Shirk RA; Whinna HC; Henriksen RA; Church FC
    J Biol Chem; 1993 Feb; 268(5):3321-7. PubMed ID: 8429008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.
    Whinna HC; Church FC
    J Protein Chem; 1993 Dec; 12(6):677-88. PubMed ID: 8136018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
    Sheehan JP; Wu Q; Tollefsen DM; Sadler JE
    J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin.
    Holland CA; Henry AT; Whinna HC; Church FC
    FEBS Lett; 2000 Nov; 484(2):87-91. PubMed ID: 11068038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
    Van Deerlin VM; Tollefsen DM
    J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
    Sheehan JP; Tollefsen DM; Sadler JE
    J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thrombin by sulfated polysaccharides isolated from green algae.
    Hayakawa Y; Hayashi T; Lee J; Srisomporn P; Maeda M; Ozawa T; Sakuragawa N
    Biochim Biophys Acta; 2000 Nov; 1543(1):86-94. PubMed ID: 11087944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II.
    Becker DL; Fredenburgh JC; Stafford AR; Weitz JI
    J Biol Chem; 1999 Mar; 274(10):6226-33. PubMed ID: 10037709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes.
    Myles T; Church FC; Whinna HC; Monard D; Stone SR
    J Biol Chem; 1998 Nov; 273(47):31203-8. PubMed ID: 9813026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.
    Bode W; Turk D; Karshikov A
    Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
    Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of heparin cofactor II anticoagulant activity.
    Bauman SJ; Church FC
    J Biol Chem; 1999 Dec; 274(49):34556-65. PubMed ID: 10574918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition.
    Derechin VM; Blinder MA; Tollefsen DM
    J Biol Chem; 1990 Apr; 265(10):5623-8. PubMed ID: 2138609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin cofactor II-dependent antithrombin activity of calcium spirulan.
    Hayakawa Y; Hayashi T; Hayashi K; Hayashi T; Ozawa T; Niiya K; Sakuragawa N
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):554-60. PubMed ID: 8874866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of lysine 173 in heparin binding to heparin cofactor II.
    Whinna HC; Blinder MA; Szewczyk M; Tollefsen DM; Church FC
    J Biol Chem; 1991 May; 266(13):8129-35. PubMed ID: 1902471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition.
    Mitchell JW; Church FC
    J Biol Chem; 2002 May; 277(22):19823-30. PubMed ID: 11856753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II.
    Cooper ST; Rezaie AR; Esmon CT; Church FC
    Thromb Res; 2002 Jul; 107(1-2):67-73. PubMed ID: 12413592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II.
    Hortin GL; Tollefsen DM; Benutto BM
    J Biol Chem; 1989 Aug; 264(24):13979-82. PubMed ID: 2760054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mapping of the thrombin-heparin cofactor II complex.
    Fortenberry YM; Whinna HC; Gentry HR; Myles T; Leung LL; Church FC
    J Biol Chem; 2004 Oct; 279(41):43237-44. PubMed ID: 15292227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.